Overview

The Chapman Lab conducts research at the intersection of nanotechnology, immunology, and translational medicine. We focus on the design of targeted vaccines and therapeutics for infectious diseases and autoimmune disorders, with particular emphasis on modulating B cell responses and understanding germinal center biology. Our research integrates bioconjugation chemistry, protein engineering, and drug delivery to develop next-generation nanomedicines that enable precise control of immune responses.